Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing
This paper describes nine instances of positive anti-doping tests that could be accounted for by the use of permitted generic prescription drugs contaminated with diuretics, which are prohibited in sport at all times under the WADA Prohibited List. The contamination levels found in the medications a...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4eef0f70092f49fe8daacc537daa353a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4eef0f70092f49fe8daacc537daa353a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4eef0f70092f49fe8daacc537daa353a2021-11-17T07:05:24ZGeneric Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing2624-936710.3389/fspor.2021.692244https://doaj.org/article/4eef0f70092f49fe8daacc537daa353a2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fspor.2021.692244/fullhttps://doaj.org/toc/2624-9367This paper describes nine instances of positive anti-doping tests that could be accounted for by the use of permitted generic prescription drugs contaminated with diuretics, which are prohibited in sport at all times under the WADA Prohibited List. The contamination levels found in the medications are reported and were below FDA limits for manufacturers that are based primarily on safety considerations. These cases demonstrate that great care must be taken to identify the source of low-level anti-doping positives for diuretics reported by WADA-accredited laboratories, and possibly other prohibited substances as well, in order to avoid sanctioning innocent athletes. An evaluation of the cases in this paper supports an approach which establishes a laboratory minimum reporting level (MRL) for diuretics found most commonly in medications. A global consensus after extensive review of similar anti-doping cases has resulted in implementation of a recently announced solution regarding potential diuretic contamination cases.Amy EichnerLaura A. LewisBridget LeonardRyan M. Van WagonerDaniel EichnerMatthew N. FedorukFrontiers Media S.A.articleprescription medicationanti-dopingrule violationminimum reporting leveladverse analytical findingSportsGV557-1198.995ENFrontiers in Sports and Active Living, Vol 3 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
prescription medication anti-doping rule violation minimum reporting level adverse analytical finding Sports GV557-1198.995 |
spellingShingle |
prescription medication anti-doping rule violation minimum reporting level adverse analytical finding Sports GV557-1198.995 Amy Eichner Laura A. Lewis Bridget Leonard Ryan M. Van Wagoner Daniel Eichner Matthew N. Fedoruk Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing |
description |
This paper describes nine instances of positive anti-doping tests that could be accounted for by the use of permitted generic prescription drugs contaminated with diuretics, which are prohibited in sport at all times under the WADA Prohibited List. The contamination levels found in the medications are reported and were below FDA limits for manufacturers that are based primarily on safety considerations. These cases demonstrate that great care must be taken to identify the source of low-level anti-doping positives for diuretics reported by WADA-accredited laboratories, and possibly other prohibited substances as well, in order to avoid sanctioning innocent athletes. An evaluation of the cases in this paper supports an approach which establishes a laboratory minimum reporting level (MRL) for diuretics found most commonly in medications. A global consensus after extensive review of similar anti-doping cases has resulted in implementation of a recently announced solution regarding potential diuretic contamination cases. |
format |
article |
author |
Amy Eichner Laura A. Lewis Bridget Leonard Ryan M. Van Wagoner Daniel Eichner Matthew N. Fedoruk |
author_facet |
Amy Eichner Laura A. Lewis Bridget Leonard Ryan M. Van Wagoner Daniel Eichner Matthew N. Fedoruk |
author_sort |
Amy Eichner |
title |
Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing |
title_short |
Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing |
title_full |
Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing |
title_fullStr |
Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing |
title_full_unstemmed |
Generic Pharmaceuticals as a Source of Diuretic Contamination in Athletes Subject to Sport Drug Testing |
title_sort |
generic pharmaceuticals as a source of diuretic contamination in athletes subject to sport drug testing |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/4eef0f70092f49fe8daacc537daa353a |
work_keys_str_mv |
AT amyeichner genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting AT lauraalewis genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting AT bridgetleonard genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting AT ryanmvanwagoner genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting AT danieleichner genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting AT matthewnfedoruk genericpharmaceuticalsasasourceofdiureticcontaminationinathletessubjecttosportdrugtesting |
_version_ |
1718425857360396288 |